Microcyn

4 stories · following the connections

Business

Sonoma Pharmaceuticals Receives Brazilian Approvals to Market Multiple Hypochlorous Acid-Based Dermatology Products

By Nasdaq OMXOct 31, 2017, 11:45 AM UTC

Business

Sonoma Pharmaceuticals Announces Commercialization of MicrocynAH® Animal Healthcare Products in Japan

By Nasdaq OMXSep 14, 2017, 8:05 AM UTC

Business

Oculus Innovative Sciences Announces Fiscal Second Quarter 2017 Financial Results and Conference Call

By Nasdaq OMXOct 27, 2016, 8:05 AM UTC

Business

Oculus Innovative Sciences Receives European CE Mark for New MucoClyns™ for First Responders

By Nasdaq OMXJan 14, 2016, 9:05 AM UTC